COVID-19 pandemic
Estonia suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following a report of a possible link with cases of blood clotting.
Sources: Eesti Rahvusringhääling
Changes
- Estonia suspends the use of the Oxford–AstraZeneca vaccine to people over 60 years old following report of possible link with the blood clotting cases.
- The Ministry of Health temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with very rare blood clotting.
- Estonia suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following a report of a possible link with cases of blood clotting.
- The Ministry of Health restricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with very rare blood clotting.
- Belgium temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 55 years old following a report from the European Medicines Agency that there is a "possible link" between the vaccine and very rare blood clotting cases.
- Estonia suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following a report of a possible link with cases of blood clotting.